GPCR
Price
$69.69
Change
-$1.60 (-2.24%)
Updated
Dec 24 closing price
Capitalization
4.92B
Intraday BUY SELL Signals
NRIX
Price
$19.36
Change
+$0.07 (+0.36%)
Updated
Dec 24 closing price
Capitalization
1.96B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs NRIX

Header iconGPCR vs NRIX Comparison
Open Charts GPCR vs NRIXBanner chart's image
Structure Therapeutics
Price$69.69
Change-$1.60 (-2.24%)
Volume$745.37K
Capitalization4.92B
Nurix Therapeutics
Price$19.36
Change+$0.07 (+0.36%)
Volume$480.46K
Capitalization1.96B
GPCR vs NRIX Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GPCR vs. NRIX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (GPCR: $69.69 vs. NRIX: $19.36)
Brand notoriety: GPCR and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 44% vs. NRIX: 24%
Market capitalization -- GPCR: $4.92B vs. NRIX: $1.96B
GPCR [@Biotechnology] is valued at $4.92B. NRIX’s [@Biotechnology] market capitalization is $1.96B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GPCR and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 5 bullish, 3 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GPCR is a better buy in the short-term than NRIX.

Price Growth

GPCR (@Biotechnology) experienced а +16.21% price change this week, while NRIX (@Biotechnology) price change was +6.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($4.92B) has a higher market cap than NRIX($1.96B). GPCR YTD gains are higher at: 156.969 vs. NRIX (2.760). GPCR (-246.42M) and NRIX (-248.7M) have comparable annual earnings (EBITDA) . GPCR has more cash in the bank: 799M vs. NRIX (429M). GPCR has less debt than NRIX: GPCR (7.09M) vs NRIX (56.5M). NRIX has higher revenues than GPCR: NRIX (83.7M) vs GPCR (0).
GPCRNRIXGPCR / NRIX
Capitalization4.92B1.96B251%
EBITDA-246.42M-248.7M99%
Gain YTD156.9692.7605,687%
P/E RatioN/AN/A-
Revenue083.7M-
Total Cash799M429M186%
Total Debt7.09M56.5M13%
TECHNICAL ANALYSIS
Technical Analysis
GPCRNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
87%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MURRX24.660.10
+0.41%
MFS Utilities R2
TQVAX19.140.06
+0.31%
T. Rowe Price Integrated US LCV Eq Adv
ETHSX13.390.04
+0.30%
Eaton Vance Worldwide Health Sci A
MCPRX23.210.06
+0.26%
MFS Mid Cap Growth R2
MNMCX14.700.03
+0.20%
Manning & Napier Pro-Blend Mod Term L

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with WVE. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-2.24%
WVE - GPCR
69%
Closely correlated
+4.41%
KYMR - GPCR
50%
Loosely correlated
-0.48%
FULC - GPCR
50%
Loosely correlated
+1.87%
OCUL - GPCR
48%
Loosely correlated
-0.24%
NRIX - GPCR
43%
Loosely correlated
+0.36%
More